Process development for the production of an E. coli produced clinical grade recombinant malaria vaccine for Plasmodium vivax.

MLA

Bell, Brian A., et al. “Process Development for the Production of an E. Coli Produced Clinical Grade Recombinant Malaria Vaccine for Plasmodium Vivax.” Vaccine, vol. 27, no. 9, Feb. 2009, pp. 1448–53. EBSCOhost, https://doi.org/10.1016/j.vaccine.2008.12.027.

APA

Bell, B. A., Wood, J. F., Bansal, R., Ragab, H., Cargo, J., 3rd, Washington, M. A., Wood, C. L., Ware, L. A., Ockenhouse, C. F., & Yadava, A. (2009). Process development for the production of an E. coli produced clinical grade recombinant malaria vaccine for Plasmodium vivax. Vaccine, 27(9), 1448–1453. https://doi.org/10.1016/j.vaccine.2008.12.027

Chicago

Bell, Brian A, James F Wood, Reeta Bansal, Hatem Ragab, John Cargo 3rd, Michael A Washington, Chloe L Wood, Lisa A Ware, Christian F Ockenhouse, and Anjali Yadava. 2009. “Process Development for the Production of an E. Coli Produced Clinical Grade Recombinant Malaria Vaccine for Plasmodium Vivax.” Vaccine 27 (9): 1448–53. doi:10.1016/j.vaccine.2008.12.027.